Determining the worldwide epidemiology of surgical site infections after abdominal surgery


GlobalSurg 2 is published in Lancet Infectious Diseases Explore the dataset at Thank you to all our collaborators for making the study a success

Explore the full GlobalSurg 2 dataset on our new data visualisation application

Patients in LMIC are 60% more likely to suffer an SSI

Is 3 times longer for patients with an SSI

Is more prevalent in LMIC

About GlobalSurg 2

GlobalSurg 2 aimed to determine worldwide surgical site infection (SSI) rates following gastrointestinal surgery. The primary outcome measure for the study was 30 day surgical site infection rate.

Teams of 3 collaborators collected data for two week periods on all consecutive (i.e. one after the other) patients undergoing elective or emergency gastrointestinal surgery. There was no minimum number of patients per centre, so long as all eligible patients during the two week data collection period were included. Teams could collect any two week period they wished between Jan and July 2016, with 30 day follow up. Multiple teams at any participating centre were encouraged provided they collected non-overlapping two-week periods, and each team could collect one than one two week period if they wished.30 datapoints per patient were collected via a secure online website.

View the GlobalSurg 2 results in a snapshot